Fig. 7From: A critical overview of current progress for COVID-19: development of vaccines, antiviralĀ drugs, and therapeutic antibodiesTherapeutics drug distribution and efficacy against COVID-19. A Distribution of COVID-19 therapeutics from Nov 9, 2020 to Apr 24, 2022 in USA. B Total Distribution percentage of antiviral reagents and neutralizing antibodies doses from Nov 9, 2020 to Apr 24, 2022 in USA. The data was adopted from U.S. Department of Health & Human Service (https://aspr.hhs.gov/COVID-19/Therapeutics/Distribution/Pages/default.aspx). CĀ Effectiveness of therapeutic reagents on reducing hospitalization and deaths of COVID-19 patientsBack to article page